EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Endotrophin Measured by PRO ‐ C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease

Thomas Wiggers iD, Emilie Toft Skovgaard iD, Morten Karsdal, Jens Juul Holst iD, Frederik Christiansen, Andressa de Zawadzki, Diana Julie Leeming iD, Keyur Patel iD

Liver International · 2026

DOI: 10.1111/liv.70824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Thomas Wiggers und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Liver Cirrhosis, Peptide Fragments, Collagen Type VI, Hepatitis C, Chronic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Prognostic non‐invasive tests for liver‐related events in compensated cirrhosis are needed. Endotrophin, a fragment of type VI alpha 3 collagen involved in fibrosis and inflammation, has been associated with adverse outcomes in several chronic diseases. This study examined the association between baseline endotrophin levels, measured by nordicPRO‐C6 (PRO‐C6), and liver‐related events in advanced hepatitis C virus (HCV)‐related liver disease. Methods nordicPRO‐C6 was assessed in baseline serum from 339 patients with advanced liver fibrosis from the Hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) trial. The prognostic value of PRO‐C6 was evaluated.

Results

Baseline serum levels of PRO‐C6 were significantly higher in patients with cirrhosis and PRO‐C6 was an independent prognostic marker for liver‐related events. Each doubling of PRO‐C6 was associated with increased hazard of liver‐related events in all patients (hazard ratio (HR) = 2.22, 95% confidence interval (CI) 1.57–3.14, p < 0.0001), and in patients with cirrhosis (HR = 1.71, 95% CI 1.14–2.58, p = 0.01).

Conclusion

Endotrophin assessed by PRO‐C6 is an independent prognostic marker for liver‐related events in patients with advanced liver fibrosis and ongoing inflammation due to HCV, particularly in those with cirrhosis, from the HALT‐C trial. PRO‐C6 may be useful for risk stratification in end‐stage liver disease. However, validation in non–interferon‐treated cohorts and across chronic liver diseases of varying etiologies is required to confirm its prognostic value for liver‐related events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisPeptide FragmentsCollagen Type VIHepatitis C, ChronicHumansBiomarkersFemalePrognosisMaleMiddle AgedPredictive Value of TestsProportional Hazards ModelsAntiviral Agents

Stichwörter der Autor:innen

advanced liver diseasebiomarkercirrhosisendotrophinliver‐related eventnon‐invasive test

Substanzen

BiomarkersendotrophinPeptide FragmentsCollagen Type VIAntiviral Agents

Autor:innen und Institutionen

  • The Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Nordic Bioscience A/S, Herlev, Denmark.
  • Division of Gastroenterology and Hepatology, University Health Network, Toronto, Canada.

ORCID-Profile: Thomas Wiggers, Emilie Toft Skovgaard, Jens Juul Holst, Diana Julie Leeming, Keyur Patel

Zitieren

APA

Wiggers, T., Skovgaard, E. T., Karsdal, M., Holst, J. J., Christiansen, F., de Zawadzki, A., Leeming, D. J., & Patel, K. (2026). Endotrophin Measured by PRO ‐ C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease. Liver International. https://doi.org/10.1111/liv.70824

Vancouver

Wiggers T, Skovgaard ET, Karsdal M, Holst JJ, Christiansen F, de Zawadzki A, et al. Endotrophin Measured by PRO ‐ C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease. Liver International. 2026. doi:10.1111/liv.70824

BibTeX
@article{Wiggers2026,
  author = {Wiggers, Thomas and Skovgaard, Emilie Toft and Karsdal, Morten and Holst, Jens Juul and Christiansen, Frederik and de Zawadzki, Andressa and Leeming, Diana Julie and Patel, Keyur},
  title = {Endotrophin Measured by PRO ‐ C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70824}
}
Kostenlos starten →